Status:

TERMINATED

The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function

Lead Sponsor:

University of Liverpool

Collaborating Sponsors:

Liverpool Centre for Cardiovascular Science

Liverpool Heart and Chest Hospital NHS Foundation Trust

Conditions:

Atrial Fibrillation

Chronic Kidney Disease

Eligibility:

All Genders

18+ years

Brief Summary

This study is designed to investigate the role of lipids/lipoproteins as a potential cause for the harmful changes seen in fibrin clot properties with renal dysfunction and atrial fibrillation

Detailed Description

This is a prospective, observational, blinded study that will be conducted in two parts. The first study will assess the relationship between lipids/lipoproteins and fibrin clot properties among antic...

Eligibility Criteria

Inclusion

  • 1 Inclusion criteria
  • WP1:
  • On anticoagulation therapy
  • Informed consent obtained
  • WP2:
  • Not receiving statins prior to recruitment
  • Diagnosed atrial fibrillation
  • On anticoagulation therapy
  • Estimated glomerular filtration rate of \<50 ml/min/1.73m2
  • Informed consent obtained
  • 2 Exclusion criteria
  • Age \<18 years
  • Severe mitral stenosis or presence of metallic prosthetic valve
  • Active or recent malignancy (\<6 months)
  • Active immunological disease
  • Connective tissue disease
  • Chronic liver disease
  • Recent or chronic serious infection
  • Chronic inflammatory disease
  • Known haemophilia or thrombophilia
  • Active bleeding
  • Untreated hypothyroidism or hyperthyroidism
  • Recent surgery (\<3 months)
  • Familial lipid disorders
  • Concurrent use of steroids
  • Dietary supplements known to influence lipids
  • Contraindications/inability/unwillingness to commence statin (WP2)

Exclusion

    Key Trial Info

    Start Date :

    September 26 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2022

    Estimated Enrollment :

    56 Patients enrolled

    Trial Details

    Trial ID

    NCT04043026

    Start Date

    September 26 2019

    End Date

    August 1 2022

    Last Update

    August 8 2022

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Liverpool Heart and Chest Hospital

    Liverpool, United Kingdom

    2

    Liverpool University Hospitals NHS Foundation Trust

    Liverpool, United Kingdom

    The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function | DecenTrialz